ロード中...
Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT)
BACKGROUND: Peptide receptor radionuclide therapy (PRRT) with [(177)Lu]-DOTA-TATE is an effective treatment of neuroendocrine tumors (NETs). After each cycle of treatment, patient dosimetry evaluates the radiation dose to the risk organs, kidneys, and bone marrow, the most radiosensitive tissues. Ab...
保存先:
| 出版年: | EJNMMI Phys |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6006002/ https://ncbi.nlm.nih.gov/pubmed/29916115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40658-018-0211-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|